PMID- 29798204 OWN - NLM STAT- MEDLINE DCOM- 20181019 LR - 20220330 IS - 2096-7993 (Print) IS - 2096-7993 (Linking) VI - 32 IP - 1 DP - 2018 Jan 5 TI - [Expression of long non-coding RNA LINC00460 in laryngeal squamous cell carcinoma tissue and its clinical significance]. PG - 18-22 LID - 10.13201/j.issn.1001-1781.2018.01.004 [doi] AB - Objective:To understand the expression of LINC00460 in laryngeal squamous cell carcinoma (LSCC), and to discuss the role of LINC00460 in carcinogenesis and development of laryngeal squamous cell carcinoma. Method:The expression of LINC00460 in 68 laryngeal squamous cell carcinoma tissues and paired adjacent normal tissues were examined by real-time PCR. The relationship between the expression levels of LINC00460 and the clinicopathological features including clinical stage, histological grade, pathological type, and lymph node metastasis in LSCC was analyzed according to the clinical data. Result:The expression of LINC00460 was significantly upregulated in the LSCC tissue compared with that of adjacent normal mucosal tissue (P=0.006). There were no statistical differences of the quantity of LINC00460 expression among supraglottic, glottic and subglottic LSCC (P>0.05). Moreover, LINC00460 had no significant changes in poorly differentiated LSCC when compared with that of well and moderately differentiated LSCC (P>0.05). Furthermore, the expression of LINC00460 in LSCC with lymph node metastasis had no significant changes when compared with that without of lymph node metastasis (P>0.05). Notably, LINC00460 expression in T1+T2 stages patients were significantly lower than T3+T4 stages (P<0.05). Conclusiont:Upregulation of long non-coding RNA LINC00460 might contribute to the carcinogenesis and development of LSCC, furthermore play important biological function. CI - Copyright(c) by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery. FAU - Ge, S S AU - Ge SS AD - Department of Otolaryngology,the First Hospital of Shanxi Medical University,Taiyuan, 030001, China. FAU - Wu, Y Y AU - Wu YY AD - Department of Otolaryngology,the First Hospital of Shanxi Medical University,Taiyuan, 030001, China. FAU - Gao, W AU - Gao W AD - Department of Otolaryngology,the First Hospital of Shanxi Medical University,Taiyuan, 030001, China. FAU - Zhang, C M AU - Zhang CM AD - Department of Otolaryngology,the First Hospital of Shanxi Medical University,Taiyuan, 030001, China. FAU - Hou, J AU - Hou J AD - Department of Otolaryngology,the First Hospital of Shanxi Medical University,Taiyuan, 030001, China. FAU - Wen, S X AU - Wen SX AD - Department of Otolaryngology,the First Hospital of Shanxi Medical University,Taiyuan, 030001, China. FAU - Wang, B Q AU - Wang BQ AD - Department of Otolaryngology,the First Hospital of Shanxi Medical University,Taiyuan, 030001, China. LA - chi PT - Journal Article PL - China TA - Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi JT - Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery JID - 101303164 RN - 0 (Biomarkers, Tumor) RN - 0 (RNA, Long Noncoding) SB - IM MH - Biomarkers, Tumor MH - Carcinoma, Squamous Cell/*diagnosis MH - Humans MH - Laryngeal Neoplasms/*diagnosis MH - Prognosis MH - RNA, Long Noncoding/*analysis OTO - NOTNLM OT - biomarker OT - invasion OT - laryngeal squamous cell carcinoma OT - long non-coding RNA OT - metastasis COIS- The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose. EDAT- 2018/05/26 06:00 MHDA- 2018/10/20 06:00 CRDT- 2018/05/26 06:00 PHST- 2017/11/02 00:00 [received] PHST- 2018/05/26 06:00 [entrez] PHST- 2018/05/26 06:00 [pubmed] PHST- 2018/10/20 06:00 [medline] AID - 10.13201/j.issn.1001-1781.2018.01.004 [doi] PST - ppublish SO - Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Jan 5;32(1):18-22. doi: 10.13201/j.issn.1001-1781.2018.01.004.